Press release

Twist Bioscience to Report Fiscal 2019 Second Quarter Financial Results on Tuesday, April 30, 2019

Sponsored by Businesswire

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling
customers to succeed through its offering of high-quality synthetic DNA,
today announced that it will issue its financial results for the fiscal
2019 second quarter ended March 31, 2019, following the close of market
on Tuesday, April 30, 2019. The company plans to hold a conference call
and live audio webcast for analysts and investors at 4:30 p.m. Eastern
Time to discuss its financial results and provide an update on the
company’s business. The press release with the financial results will be
accessible from the company’s website prior to the conference call
through the Investor Relations section under the “Company” tab at

The call can be accessed by dialing (866) 688-0947 (domestic) or (409)
217-8781 (international) and refer to the conference ID 2244119. A
telephonic replay of the conference call will be available beginning
approximately four hours after the call through May 7, 2019 and may be
accessed by dialing (855) 859-2056 (domestic) or (404) 537-3406
(international). The replay conference ID is 2244119. The webcast replay
will be available for two weeks.

About Twist Bioscience Corporation

Twist Bioscience is a leading and rapidly growing synthetic biology
company that has developed a disruptive DNA synthesis platform to
industrialize the engineering of biology. The core of the platform is a
proprietary technology that pioneers a new method of manufacturing
synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging
its unique technology to manufacture a broad range of synthetic
DNA-based products, including synthetic genes, tools for next-generation
sequencing (NGS) preparation, and antibody libraries for drug discovery
and development. Twist is also pursuing longer-term opportunities in
digital data storage in DNA and biologics drug discovery. Twist makes
products for use across many industries including healthcare, industrial
chemicals, agriculture and academic research.

Follow us on Twitter
| Facebook
| LinkedIn
| YouTube